Y染色体AZFc区缺失患者的治疗结局分析

doi:10.3969/j.issn.1671-167X.2016.04.008

摘要/Abstract

摘要：

目的：探讨Y染色体无精子症因素（azoospermia factor，AZF）c区缺失患者治疗方案的选择。方法：对既往183例在北京大学第三医院诊治的Y染色体AZFc区缺失患者的资料进行回顾性分析，整理诊疗过程及结局，找出AZFc区缺失患者精液情况的特点。结果： 183例AZFc区缺失的患者中105例（57.4%，105/183）能够自行射出精子，其中103例（98.1%，103/105）为重度或者严重少精子症，98例通过规律的药物治疗后有6例（6.1%，6/98）自然受孕，其余99例行胞浆内单精子显微注射（intracytoplasmic sperm injection，ICSI）患者中有68例（68.7%，68/99）成功受孕。183例AZFc区缺失患者中78例临床表现为无精子症，其中49例（62.8%，49/78）先行睾丸穿刺取精术（ testicular sperm aspiration，TESA），21例（26.9%，21/78）直接行显微取精术（micro-dissection testicular sperm extraction，micro-TESE）。行TESA的患者中，17例（34.7%，17/49）找到精子，32例（65.3%，32/49）未找到精子，包括12例（37.5%，12/32）放弃治疗及20例（62.5%，20/32）选择行micro-TESE患者。截至最后随访，41位选择micro-TESE的患者中已有19例（46.3%，19/41）完成手术，其中11例（57.9%，11/19）成功找到精子，包括TESA失败后行micro-TESE的患者（6例）中的4例（66.6%，4/6）。无精子症AZFc区缺失患者中已经有7例行ICSI，4例（57.1%，4/7）成功受孕。结论： AZFc区缺失的患者中有精子者大部分为重度或严重少精子症，长期的药物治疗效果不佳，应及时行ICSI治疗；无精子的患者通过TESA取到精子的概率稍低，TESA失败后行micro-TESE取精仍有一定的成功率，因此，在某些情况下直接选择micro-TESE可以减少患者的多次受创。

关键词: 不育, 男性, Y染色体, 序列缺失, 生殖技术, 辅助, 治疗结果

Abstract:

Objective：To discuss the treatment options for patients with azoospermia factor (AZF) c microdeletion on Y chromosome. Methods: One hundred and eighty three patients, who were diagnosed as AZFc microdeletion on Y chromosome in Peking University Third Hospital, were recruited in our stu-dy. In order to get better treatment option for this kind of patients, we retrospectively analyzed their clinic data including the treatment process and pregnancy outcome and found out the characteristics of their semen. Results: Among the 183 patients, sperms can be found in ejaculated semen in 105 patients (57.4%, 105/183). One hundred and three patients (98.1%, 103/105) were diagnosed as severe or extremely severe oligospermia. Regular medication was given to 98 patients, 6 patients (6.1%, 6/98) of which got natural pregnancy. The other 99 patients who have sperms in their semen received intracytoplasmic sperm injection (ICSI), 68 patients (68.7%, 68/99) of which got pregnancy. Seventy eight patients were diagnosed as azoospermia among all the 183 patients. Forty nine patients received testicular sperm aspiration (TESA), and 21 patients choose to receive micro-TESE directly. Among the 49 patients with TESA, sperms were retrieved in 17 patients (34.7%, 17/49), and sperms were not retrieved in 32 patients (65.3%, 32/49), of which 12 patients (37.5%, 12/32) gave up treatment and 20 patients (62.5%, 20/32) choose micro-TESE. Among the 41 patients who choose to receive micro-TESE, ope-ration has been done on 19 patients, of which 11 patients (57.9%, 11/19) got sperms. Among the 11 patients, TESA has been done on 6 patients before microTESE, of which 4 patients (66.6%, 4/6) got sperms. ICSI has already been done on 7 azoospermia AZFc microdeletion patients who underwent micro-TESE, of which 4 patients (57.1%, 4/7) get pregnancy. Conclusion: AZFc microdeletion patients who had sperms were always diagnosed as severe or extremely severe oligospermia. ICSI was their first choice instead of drug therapy. For AZFc microdeletion patients who were diagnosed as azoospermia, TESA was one of their choices, however, the success rate is not high. Micro-TESE is still possible to get sperms even after the failure of TESA. Therefore, we may choose micro-TESE instead of TESA in some azoospermia patients in order to reduce surgical trauma on patients.

Key words: Infertility, male, Y chromosomes, Sequence deletion, Reproductive techniques, assisted, Treatment outcome

中图分类号:

R698.2

赵连明，姜辉，洪锴，林浩成，唐文豪，刘德风，毛加明，廉颖，马潞林. Y染色体AZFc区缺失患者的治疗结局分析[J]. 北京大学学报(医学版), 2016, 48(4): 607-611.

ZHAO Lian-ming, JIANG Hui, HONG Kai, LIN Hao-cheng, TANG Wen-hao, LIU De-feng, MAO Jia-ming, LIAN Yin, MA Lu-lin. Outcome of treatment of Y chromosome AZFc microdeletion patients[J]. Journal of Peking University(Health Sciences), 2016, 48(4): 607-611.

参考文献

相关文章 15

[1]	高加勒, 张忠涛. 局部进展期直肠癌精准治疗现状与展望[J]. 北京大学学报（医学版）, 2026, 58(2): 247-250.
[2]	付浩, 申潞艳, 黄冰洋, 马少华. 免疫治疗背景下食管鳞状细胞癌围手术期治疗的临床思考[J]. 北京大学学报（医学版）, 2026, 58(2): 266-271.
[3]	宋晓欢, 罗桂英, 王婕妤, 贾月迪, 江飞, 朱梦黎, 王丹妮. 辅助生殖人群体脂率和体骨骼肌率与抑郁的相关性研究[J]. 北京大学学报（医学版）, 2026, 58(2): 319-326.
[4]	李伟浩, 张学民, 李伟, 张韬, 张小明. 胸主动脉腔内修复术左肱动脉穿刺点使用血管缝合器处理的临床效果[J]. 北京大学学报（医学版）, 2026, 58(2): 388-392.
[5]	李嘉临, 陈力侨, 唐家天, 吴艳, 王安强. 胃肝样腺癌转化治疗1例[J]. 北京大学学报（医学版）, 2026, 58(2): 399-404.
[6]	FarinEbrahimi, 冯志强, FarazEbrahimi, 韩玮华, 于子杨, 贾宽宽, 安金刚. 上颌药物相关性颌骨坏死的不同分期手术治疗效果[J]. 北京大学学报（医学版）, 2026, 58(1): 107-114.
[7]	于录, 吴灵, 刘筱菁, 李自力. 基于数据库相似性检索的正颌外科手术规划技术流程可行性研究: 随机对照试验[J]. 北京大学学报（医学版）, 2026, 58(1): 145-152.
[8]	潘莲菲, 李文静, 王瑞洋, 焦剑, 曹战强, 高丽, 释栋. 口服抗生素辅助牙周机械治疗对重度牙周炎的短期疗效及影响因素[J]. 北京大学学报（医学版）, 2026, 58(1): 30-36.
[9]	李浙民, 季加孚, 李国新, 李子禹, 步召德, 高翔宇, 董迪, 唐磊, 邢晓芳, 贾淑芹, 郭婷, 张连海, 陕飞, 季鑫, 王安强. 胃癌精准诊疗技术的创建与推广[J]. 北京大学学报（医学版）, 2025, 57(5): 864-867.
[10]	牛远杰, 辛钟成, 林桂亭, 丁攀, 潘建成, 封玉宏, 郭应禄. 低强度激光疗法治疗男性生殖与性功能障碍[J]. 北京大学学报（医学版）, 2025, 57(4): 627-632.
[11]	陈千喜, 陈延, 郑仲杰, 唐文豪, 刘镇, 洪锴, 林浩成. 辅助生殖技术周期中不同睾丸取精方式下非梗阻性无精子症患者的精子库供精比例[J]. 北京大学学报（医学版）, 2025, 57(4): 721-726.
[12]	刘苗雨, 王思源, 裴林, 王殊. 同步应用戈舍瑞林对年轻乳腺癌患者新辅助化疗疗效的影响[J]. 北京大学学报（医学版）, 2025, 57(2): 291-297.
[13]	马丽娟, 腾雍辉, 王勇, 赵一姣, 张馨月, 秦庆钊, 尹东. 乳牙缺失数字化丝圈间隙保持器的三维有限元分析[J]. 北京大学学报（医学版）, 2025, 57(2): 376-383.
[14]	方媛媛, 徐帆, 雷杰, 张昊, 张文宇, 孙宇, 吴宏新, 傅开元, 毛伟玉. 基于颞下颌关节紊乱病诊断标准的临床自动诊断系统的建立及验证[J]. 北京大学学报（医学版）, 2025, 57(1): 192-201.
[15]	康一帆, 葛严军, 吕晓鸣, 谢尚, 单小峰, 蔡志刚. 即刻种植体支持式义齿修复的血管化髂骨瓣重建下颌骨缺损[J]. 北京大学学报（医学版）, 2025, 57(1): 78-84.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed